Search

Your search keyword '"Kazadi, Donatien"' showing total 4 results
Start Over Author "Kazadi, Donatien"
4 results on '"Kazadi, Donatien"'

1. SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali

Author

Akpa, Esther, Bah, Fatoumata Binta, Barash, Yi-Chi, Beavogui, Abdoul Habib, Biampata, Jean-Luc, Bonnett, Tyler, Brown, Shawn, Burkey, Alissa, Camara, Daouda, Camara, Sekou, Cline-Cole, Elfrida, Coulibaly, Mamadou D, Coulibaly, Nadie, Dewar, Robin, Diallo, Mountaga, Diarra, Samba, Doumbia, Seydou, Eyler, Allison, Fouth Tchos, Karine, Francis, Alyson, Grue, Louis, Highbarger, Helene, Highbarger, Jeroen, Ibanda, Augustin Mbala, Kallon, Kadé, Kindombe, Esaie Luzolu, Kingebeni, Placide Mbala, Kolié, Cece Francis, Lallemand, Perrine, Lim, Caeul, Lokilo, Emmanuel, Lumembe, Raphael, McCormack, Ashley Louise, McNay, Laura, Mukendi, Gael, Mukendi, Thierry, Muyembe, Jean Jacques, Newell, Kevin, Njoh, Wissedi, Pankwa, Isaac Balmayel, Pukuta, Elisabeth, Riziki, Yogolelo, Rupert, Adam, Samake, Seydou, Sandrus, Jennifer, Sangare, Adama, Smolskis, Mary, Souto Adeva, Gema, Stevens, Randy, Tangara, Cheick Oumar, Tounkara, Moctar, Trumbull-Kennedy, Meghan, Tshomba, Antoine, Wague, Mamadou, Weyers, Shera, Worthington, Chris, Laverdure, Sylvain, Kazadi, Donatien, Kone, Kadidia, Callier, Viviane, Dabitao, Djeneba, Dennis, Dehkontee, Haidara, Mory Cherif, Hunsberger, Sally, Mbaya, Olivier Tshiani, Ridzon, Renee, Sereti, Irini, and Shaw-Saliba, Katy

Published
2024
Full Text
View/download PDF

2. Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease

Author

Mbala-Kingebeni, Placide, Pratt, Catherine, Ruffin, Mbusa Mutafali, Pauthner, Matthias G, Bile, Faustin, Ndaye, Antoine Nkuba, Black, Allison, Lusamaki, Eddy Kinganda, Faye, Martin, Aziza, Amuri, Diagne, Moussa M, Mukadi, Daniel, White, Bailey, Hadfield, James, Gangavarapu, Karthik, Bisento, Nella, Kazadi, Donatien, Nsunda, Bibiche, Akonga, Marceline, Tshiani, Olivier, Misasi, John, Ploquin, Aurelie, Epaso, Victor, Paka, Emilia Sana, N’kasar, Yannick Tutu Tshia, Mambu, Fabrice, Edidi, Francois, Matondo, Meris, Bula, Bula, Diallo, Boubacar, Keita, Mory, Belizaire, Marie Roseline Darnycka, Fall, Ibrahima Soce, Yam, Abdoulaye, Sabue, Mulangu, Rimion, Anne W, Salfati, Elias, Torkamani, Ali, Suchard, Marc A, Crozier, Ian, Hensley, Lisa, Rambaut, Andrew, Faye, Ousmane, Sall, Amadou, Sullivan, Nancy J, Bedford, Trevor, Andersen, Kristian G, Wiley, Michael R, Ahuka-Mundeke, Steve, and Tamfum, Jean-Jacques Muyembe

Subjects
Biodefense, Vaccine Related, Prevention, Infectious Diseases, Biotechnology, Rare Diseases, Emerging Infectious Diseases, Immunization, Infection, Good Health and Well Being, Adult, Bayes Theorem, Democratic Republic of the Congo, Ebola Vaccines, Ebolavirus, Fatal Outcome, Genome, Viral, Hemorrhagic Fever, Ebola, Humans, Male, Mutation, Phylogeny, RNA, Viral, Recurrence, Medical and Health Sciences, General & Internal Medicine
Abstract

During the 2018-2020 Ebola virus disease (EVD) outbreak in North Kivu province in the Democratic Republic of Congo, EVD was diagnosed in a patient who had received the recombinant vesicular stomatitis virus-based vaccine expressing a ZEBOV glycoprotein (rVSV-ZEBOV) (Merck). His treatment included an Ebola virus (EBOV)-specific monoclonal antibody (mAb114), and he recovered within 14 days. However, 6 months later, he presented again with severe EVD-like illness and EBOV viremia, and he died. We initiated epidemiologic and genomic investigations that showed that the patient had had a relapse of acute EVD that led to a transmission chain resulting in 91 cases across six health zones over 4 months. (Funded by the Bill and Melinda Gates Foundation and others.).

Published
2021

3. Ebola Virus Transmission Initiated by Systemic Ebola Virus Disease Relapse

Author

Mbala-Kingebeni, Placide, Pratt, Catherine, Ruffin, Mbusa Mutafali, Pauthner, Matthias G., Bile, Faustin, Nkuba Ndaye, Antoine, Black, Allison, Kinganda Lusamaki, Eddy, Faye, Martin, Aziza, Amuri, Diagne, Moussa M, Mukadi, Daniel, White, Bailey, Hadfield, James, Gangavarapu, Karthik, Bisento, Nella, Kazadi, Donatien, Nsunda, Bibiche, Akonga, Marceline, Tshiani, Olivier, Misasi, John, Ploquin, Aurelie, Epaso, Victor, Sana Paka, Emilia, N’kasar, Yannick Tutu Tshia, Mambu, Fabrice, Edidi, Francois, Matondo, Meris, Bula Bula, Junior, Diallo, Boubacar, Keita, Mory, Belizaire, Marie Roseline Darnycka, Fall, Ibrahima Soce, Yam, Abdoulaye, Sabue, Mulangu, Rimion, Anne W., Salfati, Elias, Torkamani, Ali, Suchard, Marc A., Crozier, Ian, Hensley, Lisa, Rambaut, Andrew, Faye, Ousmane, Sall, Amadou, Sullivan, Nancy J., Bedford, Trevor, Andersen, Kristian G., Wiley, Michael R., Ahuka-Mundeke, Steve, and Muyembe Tamfum, Jean-Jacques

Subjects
Adult, Male, viruses, virus diseases, Bayes Theorem, Genome, Viral, Hemorrhagic Fever, Ebola, Ebolavirus, Article, Fatal Outcome, Recurrence, Mutation, Democratic Republic of the Congo, Humans, RNA, Viral, Ebola Vaccines, Phylogeny
Abstract

During the 2018-2020 Ebola virus disease (EVD) outbreak in North Kivu province in the Democratic Republic of Congo, EVD was diagnosed in a patient who had received the recombinant vesicular stomatitis virus-based vaccine expressing a ZEBOV glycoprotein (rVSV-ZEBOV) (Merck). His treatment included an Ebola virus (EBOV)-specific monoclonal antibody (mAb114), and he recovered within 14 days. However, 6 months later, he presented again with severe EVD-like illness and EBOV viremia, and he died. We initiated epidemiologic and genomic investigations that showed that the patient had had a relapse of acute EVD that led to a transmission chain resulting in 91 cases across six health zones over 4 months. (Funded by the Bill and Melinda Gates Foundation and others.).

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results